Showing results (1621-1630 of 10,079) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|October 3, 2015
Synthesis and Pharmacological Effects of the Anti-Cancer Agent 2-MethoxyestradiolEirik Johansson Solum, Øyvind W Akselsen, Anders Vik, et al.Current Pharmaceutical Design|November 12, 2015
Adipose Tissue Oxygenation in Obesity: A Matter of Cardiovascular Risk?Linda Landini, Miikka-Juhani Honka, Ele Ferrannini, et al.Current Pharmaceutical Design|November 21, 2013
Mechanisms of esophageal protection, gastroprotection and ulcer healing by melatonin. implications for the therapeutic use of melatonin in gastroesophageal reflux disease (GERD) and peptic ulcer diseaseIwona Brzozowska, Malgorzata Strzalka, Danuta Drozdowicz, et al.Current Pharmaceutical Design|November 21, 2013
Detection of melatonin production from the intestinal epithelium using electrochemical methodsPaul P Bertrand, Kate E Polglaze, Rebecca L Bertrand, et al.Current Pharmaceutical Design|November 29, 2013
Tumor dormancy and the angiogenic switch: possible implications of bone marrow- derived cellsYuval Shaked, Sandra McAllister, Ofer Fainaru, et al.Current Pharmaceutical Design|October 22, 2013
MET and ALK as targets for the treatment of NSCLCM Capelletti, F Gelsomino, M TiseoCurrent Pharmaceutical Design|October 22, 2013
MicroRNAs in non-small cell lung cancer: current status and future therapeutic promisesD Cortinovis, V Monica, F Pietrantonio, et al.Current Pharmaceutical Design|August 28, 2014
Phosphodiesterase: an interface connecting cognitive deficits to neuropsychiatric and neurodegenerative diseasesZhen-Zhen Wang, Yi Zhang, Han-Ting Zhang, et al.Current Pharmaceutical Design|September 6, 2014
Quorum sensing inhibitors as anti-biofilm agentsGilles Brackman, Tom CoenyeCurrent Pharmaceutical Design|September 6, 2014
Quorum sensing and biofilms in the pathogen, Streptococcus pneumoniaeJoana Galante, Alfred C-Y Ho, Sarah Tingey, et al.Pageof 1,008